60 degrees pharmaceuticals announces pricing of $2.4 million public offering

60 degrees pharma announces a $2.4 mil public offering, with funds to be used for working capital, relaunching arakoda for malaria prevention, and research
SXTP Ratings Summary
SXTP Quant Ranking